Health Service Executive

Dáil Éireann Debate, Wednesday - 18 September 2024

• Debates
• Find a debate
  • Dáil debates
  • Seanad debates
  • Committee debates
• Find a vote
  • Dáil votes
  • Seanad votes
  • Committee votes
• Parliamentary questions
  • Written questions
  • Oral questions
• Search tips
• Utterances having an adverse effect

Wednesday, 18 September 2024

Questions (711)

Mairéad Farrell

Question:

711. Deputy Mairéad Farrell asked the Minister for Health the reason the HSE claims to be saving €4 million per year using biosimilar teriparatide, when the cost of managing fractures is estimated to be increasing by approximately €100 million per year. [36460/24]

Written answers

Minister for Health

As this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.

• Previous Answer
• Next Answer